Popular Articles

UN climate panel to review claim on natural disasters: report
Controversy-ridden UN climate panel has said it is reassessing another of its claim for linking global warming to an increase in the number and severity of natural disasters, bringing fresh embarrassment to it. http://smallpersonalloans.org.uk

Consultants, banks to help cos raise funds for CDM projects
Raising finance for companies eyeing renewable energy projects would no more be a tough task as banks and consultants are working on innovative solutions to help these companies.

News of the day

Markets in consolidation mode
It was a day of consolidation. The markets ended flat after trading in a narrow, albeit choppy range, as they attempted to digest the gains of the past two days. The Sensex closed below the dotted line at 17,169, down 28 points, and the Nifty ended at 5,123, up a point.
Small Business

India Eco Summit: Pfizer to launch another product in India

World"s largest drug maker Pfizer today said it is in the process of bringing in synergies in operation with Wyeth, which it acquired in January this year, and will launch one more product by the end of this fiscal. - India Eco Summit: Sharma pitches for stimulus continuation - India Eco Summit: Fortis Healthcare to set up 3 more hospitals - India Eco Summit: "India at bottom half in man-woman equality index" - India Eco Summit: Ispat-Stemcor Rs 1,100-cr project to start soon - India Eco Summit: Kingfisher Airlines to raise $600 mn - India Eco Summit: ICICI to reduce stake in Firstsource "We have already introduced three products in the country in the last few months. Going forward we will be introducing one more product by the end of the current fiscal," Pfizer India Managing Director Keval Handa told reporters here on the sidelines of the India Economic Summit. Pfizer has recruited around 250 people this year for its India operations and will add another 200 to its tally next year. The company is also planning to expand to smaller cities. "To fuel the growth of Pfizer in India, we are also expanding our operations in tier-2 and tier-3 cities," Handa added. In January, Pfizer had acquired much smaller rival Wyeth for about $68 billion. Handa has also been appointed as Managing Director of Wyeth"s India operations. "As of now, Wyeth and Pfizer are two separate entities and they do not have major overlaps in terms of product portfolios and rather they complement each other," he added. The company is currently working on bringing synergies in operations of Pfizer and Wyeth in the country, he said. Asked about merger of Wyeth with Pfizer, Handa declined to comment.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):